Showcasing Preclinical Proof of Concept of Autophagy-Mediated Protein Degradation Against Aggregated Targets in the Brain
Time: 10:00 am
day: Conference Day One
Details:
- Evaluating AUTOTAC engagement and efficacy in targeted CNS protein degradation
- Detailing AUTOTAC design to ensure controlled autophagy degradation via P62 targeting
- Explaining experimental set-up and model systems utilized for testing AUTOTAC therapies
